SCHEMBL21501031

SCHEMBL21501031

CC(=O)c1ccc([C@H]2C[C@H]2C(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 7/20 0.57
▸ EPHX2 P34913 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HDAC4 P56524 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ ITGB3 P05106 1/20 0.41
▸ ITGB1 P05556 1/20 0.41
▸ ITGAV P06756 1/20 0.41
▸ ITGA2B P08514 1/20 0.41
▸ ITGB5 P18084 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SLC9A1 P19634 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23425326 1.00 FFAR1 (0.57) FFAR1EPHX2SMN1; SMN2MAPK1TDP1
SCHEMBL19388467 0.82 HPGD (0.46) EPHX2SMN1; SMN2MAPK1TDP1ALDH1A1
SCHEMBL12295869 0.82 HPGD (0.46) EPHX2SMN1; SMN2MAPK1TDP1ALDH1A1
SCHEMBL2238225 0.81 FFAR1 (0.56) FFAR1EPHX2TDP1ALDH1A1CYP1A2
SCHEMBL2332584 0.81 FFAR1 (0.56) FFAR1EPHX2TDP1ALDH1A1CYP1A2
SCHEMBL2238222 0.81 FFAR1 (0.56) FFAR1EPHX2TDP1ALDH1A1CYP1A2
SCHEMBL12466620 0.81 FFAR1 (0.81) FFAR1TDP1ALDH1A1CYP1A2CYP3A4
SCHEMBL301501 0.81 FFAR1 (0.81) FFAR1TDP1ALDH1A1CYP1A2CYP3A4
SCHEMBL799468 0.81 FFAR1 (0.81) FFAR1TDP1ALDH1A1CYP1A2CYP3A4
SCHEMBL19628622 0.81 FFAR1 (0.81) FFAR1TDP1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112312902-B Pd (II) -catalyzed enantioselective C-H arylation of free carboxylic acids 斯克里普斯研究学院 2022-02-18 — — CN disclosed
US-11021427-B2 Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids THE SCRIPPS RESEARCH INSTITUTE (US) 2021-06-01 — — US disclosed
US-20210087131-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS THE SCRIPPS RESEARCH INSTITUTE 2021-03-25 — — US disclosed
US-20210087131-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS THE SCRIPPS RESEARCH INSTITUTE 2021-03-25 — — US disclosed
WO-2019204477-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS THE SCRIPPS RESEARCH INSTITUTE (US) 2019-10-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021427-B2 Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids PDCD1, PDK3, PDCD1LG2 FFAR1 119/4885EPHX2 314/4885SMN1; SMN2 3275/4885
US-20210087131-A1 PD(II)-CATALYZED ENANTIOSELECTIVE C-H ARYLATION OF FREE CARBOXYLIC ACIDS PDCD1, PDK3, PDCD1LG2 FFAR1 124/4885EPHX2 291/4885SMN1; SMN2 3196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback